FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA Mutated -Metastatic Castrate Resistant Prostate Cancer.
暂无分享，去创建一个
M. Anscher | K. Goldberg | R. Pazdur | R. Charlab | L. Amiri-Kordestani | Shenghui Tang | A. M. Trentacosti | A. Ibrahim | J. Beaver | E. Bloomquist | Y. Gong | Shaily Arora | C. Weinstock | Xin Gao | Sarah M. Zimmerman | K. Bijwaard | Y. Ning | Elaine Chang | M. Serlemitsos-Day | Sarah M Zimmerman | Pamela S Gallagher | Oluseyi Adeniyi | Ruth Mayrosh | B. Fuller | Frances Fahnbulleh | Felicia Diggs | Ann Marie Trentacosti | Pamela S. Gallagher | Kirsten B. Goldberg